Results 131 to 140 of about 265,934 (241)
Neurobiology of Addiction is conceived as a current survey and synthesis of the most important findings in our understanding of the neurobiological mechanisms of addiction over the past 50 years.
Koob, George F., Le Moal, Michel.
core
Physiology of nicotine addiction
Nicotine acts as both stimulant and depressant to CNS. It stimulates the release of dopamine in brain which induces feelings of pleasure and, overtime, addiction.
Pratibha, Mukherjee +2 more
core +1 more source
Nighttime Waking to Smoke, Stress, and Nicotine Addiction. [PDF]
Branstetter SA, Krebs NM, Muscat JE.
europepmc +1 more source
Neuropharmacology of Nicotine Addiction and Therapeutic Strategies for Smoking Cessation. [PDF]
Hefny AA +4 more
europepmc +1 more source
Resting-state electroencephalography theta predicts neurofeedback treatment 4-month follow-up response in nicotine addiction. [PDF]
Meng Q +6 more
europepmc +1 more source
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu +15 more
wiley +1 more source
Nicotine as an odorant : a biochemical and electrophysiological study of receptors for nicotine in the olfactory epithelium of the rat [PDF]
The results suggest that nicotine vapour stimulates an in vitro olfactory preparation in three strains of rat and two strains of mouse, in a manner similar to known odorants.
Edwards, Damian Andrew
core
L-DOPA and naloxone decrease nicotine preference in C. elegans
Nicotine is a highly addictive drug that is associated with numerous negative health outcomes and remains a significant public issue. Current nicotine addiction treatments remain insufficient, with high noncompliance and relapse rates.
Cierra Turner +7 more
doaj
Cytisine-New Challenges of a Well-Known Drug in the Treatment of Nicotine Addiction. [PDF]
Bieniasz L +5 more
europepmc +1 more source
Mechanisms of Nicotine Addiction. [PDF]
Picciotto MR, Kenny PJ.
europepmc +1 more source

